| Patent application number | Description | Published |
|---|
| 20090098303 | Coatings to increase water and grease resistance of porous materials and materials having such protection - A method of improving gas, water, water vapor, and/or grease resistance of a porous material is disclosed which comprises treating th(e material with a wax, poly(vinyl alcohol), plasticizer, and optionally a polyamine. In some embodiments, an optional first treatment agent may be applied to the material prior to the application of wax and poly(vinyl alcohol), plasticizer, and optionally a polyamine. Materials that have a single coating of wax, poly(vinyl alcohol), plasticizer, and optionally a polyamine, as well as materials having a multi-layer coating that includes a first coating of a first treatment agent and a second coating of wax, poly(vinyl alcohol), plasticizer, and optionally a polyamine are also disclosed. | 04-16-2009 |
| 20100303981 | GREASE RESISTANT COATINGS, ARTICLES AND METHODS - Disclosed herein is an environmentally safe, grease resistant article comprising an absorbent substrate, a cross-linking agent, and a polymer; wherein the substrate is first coated with the cross-linking agent and is then coated with the polymer. | 12-02-2010 |
| 20100304071 | POLYOL-BASED RELEASE PAPER, ARTICLES, AND METHODS - Disclosed herein is an adhesive release article comprising an absorbent substrate, a cross-linking agent, and a polymer; wherein the substrate is first coated with the cross-linking agent and is then coated with the polymer. | 12-02-2010 |
| 20100304116 | GREASE RESISTANT COATINGS, ARTICLES AND METHODS - Disclosed herein is an environmentally safe, grease resistant article comprising an absorbent substrate, a cross-linking agent, and a polymer; wherein the substrate is first coated with the cross-linking agent and is then coated with the polymer. | 12-02-2010 |
| 20110008619 | Polyol Coatings, Articles, and Methods - Disclosed herein is an environmentally safe, grease and/or adhesion resistant article comprising an absorbent substrate, a cross-linking agent, and a polymer; wherein the substrate is first coated with the cross-linking agent and is then coated with the polymer. | 01-13-2011 |
| Patent application number | Description | Published |
|---|
| 20080260729 | Method of Treating Cancer Comprising a Vegf-B Antgonist - The present invention relates generally to the field of cancer therapy and prophylaxis. More particularly, the present invention provides growth factor antagonists which inhibit the growth of cancers including tumors and pre-cancerous tissue. Even more particularly, the present invention is directed to antagonists of vascular endothelial growth factor-B and their use to inhibit the growth of cancer including tumor tissue and pre-cancerous tissue. | 10-23-2008 |
| 20090130093 | BINDING MEMBER FOR GM-CSF RECEPTOR - Binding members for alpha chain of receptor for granulocyte macrophage colony stimulating factor (GM-CSFRα), especially antibody molecules. Use of the binding members in treating inflammatory and autoimmune diseases, e.g. rheumatoid arthritis, asthma, allergic response, multiple sclerosis, myeloid leukaemia and atherosclerosis. | 05-21-2009 |
| 20090285799 | Antibody Antagonists of Interleukin-13 Receptor Alpha1 - Antibody antagonists of human interleukin-13 receptor alpha 1 are disclosed. The antibody molecules are useful in the inhibition of IL-13Rα1-mediated activities and, accordingly, present desirable antagonists for the use in the treatment of conditions associated with hIL-13Rα1 activity. The present invention also discloses nucleic acid encoding said antibody molecules, vectors, host cells, and compositions comprising the antibody molecules. Methods of using the antibody molecules for inhibiting or antagonizing IL-13Rα1-mediated activities are also disclosed. | 11-19-2009 |
| 20110052597 | Anti-IL-13R Alpha1 Antibodies and Their Uses Thereof - Antibody antagonists of human interleukin-13 receptor alpha 1 which bind to hIL-13Rα1 through domain 3 of the extracellular region of the receptor and inhibit IL-13 receptor-mediated signaling by IL-13 are disclosed herein. These antibodies have uses inter alia in the treatment or prevention of IL-13-related disorders and diseases. The present invention also discloses nucleic acid encoding said antibody molecules, vectors, host cells, and compositions comprising the antibody molecules. Methods of using the antibody molecules for inhibiting or antagonizing hIL-13Rα1-mediated activities are also disclosed. | 03-03-2011 |
